SST and neoplasm: Binding to somatostatin receptors (SSTRs), somatostatin contributes to the regulation of tumor growth blocking the cell cycle and producing potential antiproliferative effects.11 Considering the potent effect and short half-time of somatostatin, synthetic SST analogs, like octreotide, pasireotide, and lanreotide have been used for experimental drug trials in human oncology.12